BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17615053)

  • 1. Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk.
    Bethke L; Webb E; Sellick G; Rudd M; Penegar S; Withey L; Qureshi M; Houlston R
    BMC Cancer; 2007 Jul; 7():123. PubMed ID: 17615053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk.
    Sainz J; Rudolph A; Hein R; Hoffmeister M; Buch S; von Schönfels W; Hampe J; Schafmayer C; Völzke H; Frank B; Brenner H; Försti A; Hemminki K; Chang-Claude J
    Endocr Relat Cancer; 2011 Apr; 18(2):265-76. PubMed ID: 21317201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study.
    Balaguer F; Castellví-Bel S; Castells A; Andreu M; Muñoz J; Gisbert JP; Llor X; Jover R; de Cid R; Gonzalo V; Bessa X; Xicola RM; Pons E; Alenda C; Payá A; Piqué JM;
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):379-87. PubMed ID: 17368238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences.
    Timofeeva MN; Kropp S; Sauter W; Beckmann L; Rosenberger A; Illig T; Jäger B; Mittelstrass K; Dienemann H; ; Bartsch H; Bickeböller H; Chang-Claude JC; Risch A; Wichmann HE
    Carcinogenesis; 2009 Jul; 30(7):1161-9. PubMed ID: 19414505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps.
    Poole EM; Bigler J; Whitton J; Sibert JG; Potter JD; Ulrich CM
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):502-8. PubMed ID: 16537708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype.
    Abulí A; Bessa X; González JR; Ruiz-Ponte C; Cáceres A; Muñoz J; Gonzalo V; Balaguer F; Fernández-Rozadilla C; González D; de Castro L; Clofent J; Bujanda L; Cubiella J; Reñé JM; Morillas JD; Lanas A; Rigau J; García AM; Latorre M; Saló J; Fernández Bañares F; Argüello L; Peña E; Vilella A; Riestra S; Carreño R; Paya A; Alenda C; Xicola RM; Doyle BJ; Jover R; Llor X; Carracedo A; Castells A; Castellví-Bel S; Andreu M;
    Gastroenterology; 2010 Sep; 139(3):788-96, 796.e1-6. PubMed ID: 20638935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of colorectal adenomas in Italian subjects carrying the p53 PIN3 A2-Pro72 haplotype.
    Perfumo C; Bonelli L; Menichini P; Inga A; Gismondi V; Ciferri E; Percivale P; Bianchi Scarrà G; Nasti S; Fronza G; Varesco L
    Digestion; 2006; 74(3-4):228-35. PubMed ID: 17374954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case-only study of interactions between metabolic enzymes and smoking in colorectal cancer.
    Fan C; Jin M; Chen K; Zhang Y; Zhang S; Liu B
    BMC Cancer; 2007 Jun; 7():115. PubMed ID: 17603900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer.
    van der Logt EM; Bergevoet SM; Roelofs HM; Te Morsche RH; Dijk Yv; Wobbes T; Nagengast FM; Peters WH
    Mutat Res; 2006 Jan; 593(1-2):39-49. PubMed ID: 16039674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic.
    Pardini B; Naccarati A; Novotny J; Smerhovsky Z; Vodickova L; Polakova V; Hanova M; Slyskova J; Tulupova E; Kumar R; Bortlik M; Barale R; Hemminki K; Vodicka P
    Mutat Res; 2008 Feb; 638(1-2):146-53. PubMed ID: 17991492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coding region polymorphisms in the CHFR mitotic stress checkpoint gene are associated with colorectal cancer risk.
    Kang HC; Kim IJ; Jang SG; Hong SH; Hwang JA; Shin HR; Park JG
    Cancer Lett; 2008 Feb; 260(1-2):170-9. PubMed ID: 18079053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of COX2 -765G>C and c.3618A>G polymorphisms on the risk and survival of sporadic colorectal cancer.
    Iglesias D; Nejda N; Azcoita MM; Schwartz S; González-Aguilera JJ; Fernández-Peralta AM
    Cancer Causes Control; 2009 Oct; 20(8):1421-9. PubMed ID: 19468846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect.
    Pechlivanis S; Pardini B; Bermejo JL; Wagner K; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
    Endocr Relat Cancer; 2007 Sep; 14(3):733-40. PubMed ID: 17914103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.
    Hazra A; Chanock S; Giovannucci E; Cox DG; Niu T; Fuchs C; Willett WC; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):311-9. PubMed ID: 18268114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes.
    Rudolph A; Sainz J; Hein R; Hoffmeister M; Frank B; Försti A; Brenner H; Hemminki K; Chang-Claude J
    Endocr Relat Cancer; 2011 Jun; 18(3):371-84. PubMed ID: 21490239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
    Polakova V; Pardini B; Naccarati A; Landi S; Slyskova J; Novotny J; Vodickova L; Bermejo JL; Hanova M; Smerhovsky Z; Tulupova E; Kumar R; Hemminki K; Vodicka P
    Hum Mutat; 2009 Apr; 30(4):661-8. PubMed ID: 19224585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of estrogen-related genes jointly confer susceptibility to human spermatogenic defect.
    Su MT; Chen CH; Kuo PH; Hsu CC; Lee IW; Pan HA; Chen YT; Kuo PL
    Fertil Steril; 2010 Jan; 93(1):141-9. PubMed ID: 18980759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.
    Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Colman H; Le Neel T; Le Houérou C; Faroux R; Ollivry J; Lafraise B; Chupin LD; Sébille V; Bézieau S
    BMC Cancer; 2008 Nov; 8():326. PubMed ID: 18992148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin promoter polymorphisms and prognosis in colorectal cancer.
    Wilkening S; Tavelin B; Canzian F; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P; Försti A
    Carcinogenesis; 2008 Jun; 29(6):1202-6. PubMed ID: 18448485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
    Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A
    Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.